Test Id : ROTA
Rotavirus Antigen, Feces
Useful For
Suggests clinical disorders or settings where the test may be helpful
Investigation of patients with diarrhea, particularly infants, the
Investigation of nosocomial diarrhea
Testing Algorithm
Delineates situations when tests are added to the initial order. This includes reflex and additional tests.
For information on other diagnostic tests that may be useful in the evaluation of a patient with diarrhea, see Laboratory Testing for Infectious Causes of Diarrhea.
Method Name
A short description of the method used to perform the test
Enzyme Immunoassay (EIA)
NY State Available
Indicates the status of NY State approval and if the test is orderable for NY State clients.
Reporting Name
Lists a shorter or abbreviated version of the Published Name for a test
Testing Algorithm
Delineates situations when tests are added to the initial order. This includes reflex and additional tests.
For information on other diagnostic tests that may be useful in the evaluation of a patient with diarrhea, see Laboratory Testing for Infectious Causes of Diarrhea.
Specimen Type
Describes the specimen type validated for testing
Fecal
Specimen Required
Defines the optimal specimen required to perform the test and the preferred volume to complete testing
Specimen Type: Fresh unpreserved feces
Supplies: Stool Collection Kit, Random (T635)
Container/Tube:
Preferred: Sterile fecal container
Acceptable: Swab
Specimen Volume: 5 to 10 grams
Collection Instructions: Place specimen in a tightly sealed plastic bag.
Special Instructions
Library of PDFs including pertinent information and forms related to the test
Forms
If not ordering electronically, complete, print, and send 1 of the following forms with the specimen:
-Microbiology Test Request (T244)
Specimen Minimum Volume
Defines the amount of sample necessary to provide a clinically relevant result as determined by the testing laboratory. The minimum volume is sufficient for one attempt at testing.
1 g
Reject Due To
Identifies specimen types and conditions that may cause the specimen to be rejected
| Grossly bloody (containing no visible feces) Very mucoid feces Feces received in any preservative (example: Ecofix, formalin, PVA, C and S media) | Reject |
Specimen Stability Information
Provides a description of the temperatures required to transport a specimen to the performing laboratory, alternate acceptable temperatures are also included
| Specimen Type | Temperature | Time | Special Container |
|---|---|---|---|
| Fecal | Frozen (preferred) | 7 days | |
| Refrigerated | 72 hours |
Useful For
Suggests clinical disorders or settings where the test may be helpful
Investigation of patients with diarrhea, particularly infants, the
Investigation of nosocomial diarrhea
Testing Algorithm
Delineates situations when tests are added to the initial order. This includes reflex and additional tests.
For information on other diagnostic tests that may be useful in the evaluation of a patient with diarrhea, see Laboratory Testing for Infectious Causes of Diarrhea.
Clinical Information
Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test
Rotavirus is a major cause of nonbacterial gastroenteritis, especially in infants and very young children (6 months-2 years of age) who have not received the rotavirus vaccine. Infection may be entirely asymptomatic or produce a spectrum of disease ranging from mild gastroenteritis to severe diarrhea and vomiting with dehydration. Infection usually begins acutely and lasts for 4 to 8 days. In temperate climates, rotaviral infections are seasonal; they peak in frequency during the winter months and are uncommon during the summer. Rotaviral gastroenteritis is, therefore, sometimes called "winter vomiting disease."
Infection is more likely to be symptomatic in preterm infants, immunosuppressed patients, and elderly individuals, especially those living in nursing homes or other confined quarters. In other children and adults, rotavirus infections are usually subclinical and may be associated with asymptomatic shedding of rotavirus in the feces.
Rapid and accurate detection of rotavirus antigens in fecal specimens may lead to better patient management, particularly in hospitalized or institutionalized patients.
Reference Values
Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.
Negative
Interpretation
Provides information to assist in interpretation of the test results
Peak viral counts are reported to occur on days 3 to 5 after onset of symptoms. The virus is eliminated from the infected individual within a few days following acute infection. Specimens collected 8 days or more after onset of symptoms may not contain enough rotavirus antigen to produce a positive reaction.
A prolonged carrier state has been recognized with rotavirus infection.
The rate of positive test results may vary due to age, weather, seasonal factors, geographic location, and the general health environment for the group under study.
Information on other diagnostic tests that may be of value in evaluating patients with diarrhea can be found in Laboratory Testing for Infectious Causes of Diarrhea.
Cautions
Discusses conditions that may cause diagnostic confusion, including improper specimen collection and handling, inappropriate test selection, and interfering substances
Fecal specimens should be collected as soon after onset of symptoms as possible.
Do not collect specimens in containers having media, preservatives, animal serum, or detergent as any of these may interfere with the assay.
A positive result does not preclude the presence of other pathogenic organisms. While the relationship between rotavirus and gastroenteritis is well established, coinfection with bacterial or parasitic pathogens is possible. If suspected, testing for other enteric pathogens should be performed in parallel with the rotavirus antigen test.
Results of the rotavirus antigen assay must be interpreted with caution. A negative result does not exclude the possibility of rotavirus infection, as too small a quantity of virus or inadequate or improper sampling may cause a false-negative result.
Supportive Data
This enzyme immunoassay antigen detection method has 100% sensitivity and 92% specificity when compared to transmission electron microscopy (EM), the method initially used to detect virus in fecal and intestinal biopsy specimens and the standard to which rotavirus diagnostic tests are compared. When compared to EM and RNA analysis, in combination, the specificity increases to 97%.
Clinical Reference
Recommendations for in-depth reading of a clinical nature
Centers for Disease Control and Prevention: Rotavirus. Updated March 26, 2021. Accessed August 28,2023. Available at www.cdc.gov/rotavirus/index.html
Method Description
Describes how the test is performed and provides a method-specific reference
This US Food and Drug Administration-approved kit utilizes monoclonal antibodies in a solid-phase sandwich type enzyme immunoassay (EIA). Plastic microtiter wells are coated with a monoclonal antibody directed against the product of the sixth viral gene (VP6), which is the group-specific antigen for all known human rotaviruses. An aliquot of fecal suspension is added to the well and incubated simultaneously with an anti-rotavirus monoclonal antibody conjugated to horseradish peroxidase, resulting in the rotavirus antigen being sandwiched between the solid-phase and enzyme-linked antibodies. After 60 minutes incubation at ambient temperature, the specimen well is washed to remove unbound enzyme-labeled antibodies. Enzyme substrate (urea peroxidase) and chromogen tetra methylbenzidine are added to the wells and incubated for 10 minutes at ambient temperature. The enzyme bound in the wells converts the colorless substrate to a blue color. The intensity of the blue color is directly proportional to the concentration of rotavirus antigen in the specimen.(Package insert: Premier Rotaclone EIA for detection of Rotavirus Antigen in Human Fecal Samples. Meridian Bioscience; 01/2015)
PDF Report
Indicates whether the report includes an additional document with charts, images or other enriched information
Day(s) Performed
Outlines the days the test is performed. This field reflects the day that the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time before the test is performed. Some tests are listed as continuously performed, which means that assays are performed multiple times during the day.
Monday through Friday
Report Available
The interval of time (receipt of sample at Mayo Clinic Laboratories to results available) taking into account standard setup days and weekends. The first day is the time that it typically takes for a result to be available. The last day is the time it might take, accounting for any necessary repeated testing.
Specimen Retention Time
Outlines the length of time after testing that a specimen is kept in the laboratory before it is discarded
Performing Laboratory Location
Indicates the location of the laboratory that performs the test
Fees :
Several factors determine the fee charged to perform a test. Contact your U.S. or International Regional Manager for information about establishing a fee schedule or to learn more about resources to optimize test selection.
- Authorized users can sign in to Test Prices for detailed fee information.
- Clients without access to Test Prices can contact Customer Service 24 hours a day, seven days a week.
- Prospective clients should contact their account representative. For assistance, contact Customer Service.
Test Classification
Provides information regarding the medical device classification for laboratory test kits and reagents. Tests may be classified as cleared or approved by the US Food and Drug Administration (FDA) and used per manufacturer instructions, or as products that do not undergo full FDA review and approval, and are then labeled as an Analyte Specific Reagent (ASR) product.
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.
CPT Code Information
Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Clinic Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.
CPT codes are provided by the performing laboratory.
CPT codes are provided by the performing laboratory.
87425
LOINC® Information
Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the order and results codes of this test. LOINC values are provided by the performing laboratory.
| Test Id | Test Order Name | Order LOINC Value |
|---|---|---|
| ROTA | Rotavirus Ag, F | 5880-0 |
| Result Id | Test Result Name |
Result LOINC Value
Applies only to results expressed in units of measure originally reported by the performing laboratory. These values do not apply to results that are converted to other units of measure.
|
|---|---|---|
| 24082 | Rotavirus Ag, F | 5880-0 |